Physician profile
Bhavin Suthar
NPI 1376574459
$1,125.74
in general payments reported to CMS, 2019-2025
19 companies · $38.02 in 2025
The $38.02 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $74.53 · 2021: $92.97 · 2022: $47.91 · 2023: $308 · 2024: $239 · 2025: $38.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $346.93 | 2021-2025 | Intellis Adaptivestim, Pillcam, Inceptiv |
| Collegium Pharmaceutical, INC. | $233.53 | 2019-2024 | Belbuca, Xtampza |
| Abbott Laboratories | $128.03 | 2019-2024 | Proclaim |
| Ibsa Pharma INC. | $60.99 | 2021-2024 | Tirosint, Licart, Tirosint |
| Pfizer INC. | $49.97 | 2019 | |
| Amgen INC. | $37.43 | 2019-2020 | |
| Daiichi Sankyo INC. | $37.29 | 2019 | |
| Medtronic USA, INC. | $31.07 | 2019-2020 | |
| Nevro Corp. | $26.41 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.38 | 2019 | |
| Amneal Pharmaceuticals LLC | $23.07 | 2023 | Lyvispah |
| Grt US Holding, INC. | $22.48 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.69 | 2025 | |
| Boston Scientific Corporation | $17.58 | 2024 | |
| Kaleo, INC. | $15.11 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $13.25 | 2019 | |
| Currax Pharmaceuticals LLC | $12.98 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.84 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhavin Suthar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.